PubMed for id: 2287780802

Year	Number of Results
1998	1
1999	1
2000	1
2004	1
2005	2
2009	1
2018	1
2019	1
2020	1
2021	1
2024	0

1

Endocytosis of the non-catalytic ADAM23: Recycling and long half-life properties.

Souza ILM, Oliveira NH, Huamaní PAM, Martin AS, Borgonovo ZLM, Nakao LS, Zanata SM. Souza ILM, et al. Exp Cell Res. 2021 Jan 15;398(2):112415. doi: 10.1016/j.yexcr.2020.112415. Epub 2020 Dec 6. Exp Cell Res. 2021. PMID: 33296662

2

A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease-free survival in low-risk breast cancer patients.

Zmetakova I, Kalinkova L, Smolkova B, Horvathova Kajabova V, Cierna Z, Danihel L, Bohac M, Sedlackova T, Minarik G, Karaba M, Benca J, Cihova M, Buocikova V, Miklikova S, Mego M, Fridrichova I. Zmetakova I, et al. Cancer Sci. 2019 May;110(5):1695-1704. doi: 10.1111/cas.13985. Epub 2019 Mar 18. Cancer Sci. 2019. PMID: 30815959 Free PMC article.

3

Decreased methylation in the SNAI2 and ADAM23 genes associated with de-differentiation and haematogenous dissemination in breast cancers.

Kalinkova L, Zmetakova I, Smolkova B, Minarik G, Sedlackova T, Horvathova Kajabova V, Cierna Z, Mego M, Fridrichova I. Kalinkova L, et al. BMC Cancer. 2018 Sep 6;18(1):875. doi: 10.1186/s12885-018-4783-x. BMC Cancer. 2018. PMID: 30189837 Free PMC article.

4

Promoter hypermethylation of the ADAM23 gene in colorectal cancer cell lines and cancer tissues.

Choi JS, Kim KH, Jeon YK, Kim SH, Jang SG, Ku JL, Park JG. Choi JS, et al. Int J Cancer. 2009 Mar 15;124(6):1258-62. doi: 10.1002/ijc.24023. Int J Cancer. 2009. PMID: 19089928 Free article.

5

ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.

Takada H, Imoto I, Tsuda H, Nakanishi Y, Ichikura T, Mochizuki H, Mitsufuji S, Hosoda F, Hirohashi S, Ohki M, Inazawa J. Takada H, et al. Oncogene. 2005 Dec 1;24(54):8051-60. doi: 10.1038/sj.onc.1208952. Oncogene. 2005. PMID: 16103878

6

ADAM23 methylation and expression analysis in brain tumors.

Costa FF, Colin C, Shinjo SM, Zanata SM, Marie SK, Sogayar MC, Camargo AA. Costa FF, et al. Neurosci Lett. 2005 Jun 3;380(3):260-4. doi: 10.1016/j.neulet.2005.01.050. Epub 2005 Feb 8. Neurosci Lett. 2005. PMID: 15862898

7

Two novel isoforms of Adam23 expressed in the developmental process of mouse and human brains.

Sun YP, Deng KJ, Wang F, Zhang J, Huang X, Qiao S, Zhao S. Sun YP, et al. Gene. 2004 Jan 21;325:171-8. doi: 10.1016/j.gene.2003.10.012. Gene. 2004. PMID: 14697522

8

ADAM 23/MDC3, a human disintegrin that promotes cell adhesion via interaction with the alphavbeta3 integrin through an RGD-independent mechanism.

Cal S, Freije JM, López JM, Takada Y, López-Otín C. Cal S, et al. Mol Biol Cell. 2000 Apr;11(4):1457-69. doi: 10.1091/mbc.11.4.1457. Mol Biol Cell. 2000. PMID: 10749942 Free PMC article.

9

The identification of seven metalloproteinase-disintegrin (ADAM) genes from genomic libraries.

Poindexter K, Nelson N, DuBose RF, Black RA, Cerretti DP. Poindexter K, et al. Gene. 1999 Sep 3;237(1):61-70. doi: 10.1016/s0378-1119(99)00302-9. Gene. 1999. PMID: 10524237

10

Metalloproteinase-like, disintegrin-like, cysteine-rich proteins MDC2 and MDC3: novel human cellular disintegrins highly expressed in the brain.

Sagane K, Ohya Y, Hasegawa Y, Tanaka I. Sagane K, et al. Biochem J. 1998 Aug 15;334 ( Pt 1)(Pt 1):93-8. doi: 10.1042/bj3340093. Biochem J. 1998. PMID: 9693107 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year